Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-15

Clinical Trial Update: Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer [NA]

View source ↗

Summary

An update on a clinical trial evaluating Technetium Tc-99m sulfur colloid with blue dye for detecting sentinel lymph nodes in breast cancer; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blue dye (blue dye)
  • Technetium Tc-99m sulfur colloid (technetium-99m sulfur colloid)

Snippet

Sponsor: Centre Paul Strauss | Conditions: Breast Cancer | NA | Status: COMPLETED